Loading...
N-of-1 Trials of Expensive Biological Therapies: A Third Way?
In developing policies for use of expensive agents, such as those used for the treatment of rheumatoid arthritis, managed care organizations have invoked “stepped care,” in which physicians and patients must first try more established and less costly agents. N-of-1 clinical trials are multiple cross...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2715700/ https://ncbi.nlm.nih.gov/pubmed/18504330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinte.168.10.1030 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|